Description: Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
Home Page: www.qlinea.com
Dag Hammarskjölds väg 52A
Uppsala,
752 37
Sweden
Phone:
46 1 84 44 36 10
Officers
| Name | Title |
|---|---|
| Dr. Jonas Jarvius Ph.D. | CEO & Pres |
| Mr. Anders Lundin | CFO & Investor Relations Officer |
| Mr. Henrik Jacobsson | Chief Operating Officer |
| Ms. Ulrika Stolpe | HR Mang. |
| Ms. Tiziana Di Martino | Chief Medical Officer |
| Mr. Thomas Fritz | Chief Commercial Officer |
| Dr. Mats Gullberg | VP & Research Director |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.6765 |
| Price-to-Sales TTM: | 21.3078 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 156 |